Codes for disabilities, serious illnesses, learning difficulties and neurodevelopmental disorders

In the following table you can find the list with the disability codes used by the NKUA for classifying students admitted to the university benefiting from the regulation providing 5% (formerly 3%) additional quota for persons with disabilities; on the right column you can find the current corresponding codes used by the Greek Ministry of Education and Religious Affairs. No data in this table will be deleted or modified, whereas new data may be added.
Unfortunately, the Greek Ministry of Education and Religious Affairs changes the list with the disability codes by adding or deleting disabilities and diseases every year.

Search:

NKUA Code	Short description	Greek Ministry of Education and Religious Affairs Code for the academic year 2022-2023
01	Blind	01 Blind
02	Low visual acuity	02 Low visual acuity (with a disability degree of at least 80%)
03	Deaf	03 Deaf
04	Deaf-mute	04 Deaf-mute
05	Mediterranean anemia/ Thalassemia major	05 Persons suffering from congenital hemolytic anemias undergoing blood transfusions or having severe clinical manifestations deemed disabled with a degree of disability of at least 67% (Mediterranean anemia/Beta thalassemia/Thalassemia major, sickle cell anemia, micro-sickle cell anemia, persons suffering from Mediterranean anemia/ Beta thalassemia/Thalassemia major undergoing multiple blood transfusions, hemolytic anemia due to pyruvate kinase deficiency, Diamond Blackfan anemia)
06	Sickle cell anemia	05 Persons suffering from congenital hemolytic anemias undergoing blood transfusions or having severe clinical manifestations deemed disabled with a degree of disability of at least 67% (Mediterranean anemia/Beta thalassemia/Thalassemia major, sickle cell anemia, micro-sickle cell anemia, persons suffering from Mediterranean anemia/ Beta thalassemia/Thalassemia major undergoing multiple blood transfusions, hemolytic anemia due to pyruvate kinase deficiency, Diamond Blackfan anemia)
07	Micro-sickle cell anemia	05 Persons suffering from congenital hemolytic anemias undergoing blood transfusions or having severe clinical manifestations deemed disabled with a degree of disability of at least 67% (Mediterranean anemia/Beta thalassemia/Thalassemia major, sickle cell anemia, micro-sickle cell anemia, persons suffering from Mediterranean anemia/ Beta thalassemia/Thalassemia major undergoing multiple blood transfusions, hemolytic anemia due to pyruvate kinase deficiency, Diamond Blackfan anemia)
08	Hydrocephalus	06 Persons with congenital hydrocephalus with permanent artificial shunting of cerebrospinal fluid accompanied by other defects such as arachnoid cyst with epileptic seizure symptoms
09	Duchenne muscular dystrophy	07 Persons suffering from Duchenne muscular dystrophy
10	Brainstem severe vascular malformation	08 Persons suffering from brainstem severe vascular malformation
11	Malignant neoplasms	09 Persons who have suffered in the past or suffer in the present from malignant neoplasms (leukemias, lymphomas, solid tumors)
12	Bund Chiari syndrome	10 Persons suffering from Bund Chiari syndrome
13	Fabry disease	11 Persons suffering from Fabry disease
14	Cystic fibrosis (of the pancreas or the lungs)	12 Persons suffering from severe cystic fibrosis of the pancreas or the lungs
15	Multiple sclerosis	13 Persons suffering from multiple sclerosis
16	Myasthenia gravis	14 Persons suffering from myasthenia gravis for which they receive pharmaceutical treatment
17	Persons suffering from kidney failure receiving hemodialysis or peritoneal dialysis	15 Persons suffering from chronic kidney failure treated with hemodialysis or peritoneal dialysis
18	Congenital bleeding diathesis – hemophilias	16 Persons suffering from congenital bleeding diathesis – hemophilia treated with coagulation factors
19	Bone Marrow Transplantation	17 Persons submitted to bone Marrow transplantation
20	Cornea transplantation	18 Persons submitted to cornea transplantation
21	Heart transplantation	19 Persons submitted to heart transplantation
22	Liver transplantation	20 Persons submitted to liver transplantation
23	Lungs transplantation	21 Persons submitted to lungs transplantation
24	Kidney transplantation	22 Persons submitted to kidney transplantation
25	Pancreas transplantation	23 Persons submitted to pancreas transplantation
26	Small bowel transplantation	24 Persons submitted to small bowel transplantation
27	Juvenile diabetes (Type 1 diabetes)	25 Persons suffering from insulin-dependent type 1 diabetes (juvenile diabetes)
28	Evans syndrome	26 Persons suffering from Evans syndrome
29	Persons suffering from Mediterranean anemia/ Thalassemia major undergoing multiple blood transfusions	05 Persons suffering from congenital hemolytic anemias undergoing blood transfusions or having severe clinical manifestations deemed disabled with a degree of disability of at least 67% (Mediterranean anemia/ Beta thalassemia/Thalassemia major, sickle cell anemia, micro-sickle cell anemia, persons suffering from Mediterranean anemia/ Beta thalassemia/Thalassemia major undergoing multiple blood transfusions, hemolytic anemia due to pyruvate kinase deficiency, Diamond Blackfan anemia)
30	Motor disabilities	27 Persons with motor disabilities deemed disabled with a degree of disability of at least 67%
31	Phenylketonuria	28 Persons suffering from phenylketonuria
32	Persons suffering from congenital thrombophilia receiving lifelong anticoagulation treatment	29 Persons suffering from congenital thrombophilia receiving lifelong anticoagulation treatment
33	Arrhythmogenic right ventricular cardiomyopathy with implanted cardioverter-defibrillator	30 Persons with arrhythmogenic right ventricular cardiomyopathy with implanted cardioverter-defibrillator
34	Gaucher disease	31 Persons with Gaucher disease
35	Complex congenital heart diseases	32 Persons suffering from complex congenital heart diseases operated or not
36	Single ventricle
37	Truncus arteriosus communis
38	Myocardial disease resulting in permanent malfunction
39	Hypertrophic cardiomyopathy	33 Persons suffering from hypertrophic cardiomyopathy
40	Pulmonary arterial hypertension	34 Persons suffering from pulmonary arterial hypertension diagnosed by right heart catheterization
41	Severe pulmonary fibrosis	35 Persons suffering from severe pulmonary fibrosis of any cause
42	Brugada syndrome	-
43	Idiopathic ventricular tachycardia	36 Persons suffering from idiopathic ventricular tachycardia with implanted defibrillator
44	Glycogen storage diseases	37 Persons suffering from glycogen storage diseases
45	Liver cirrhosis with portal hypertension	38 Persons suffering from liver cirrhosis with attested portal hypertension
46	Portal hypertension due to portal vein hypoplasia	39 Persons suffering from portal hypertension due to portal vein hypoplasia
47	Crohn’s disease	40 Persons suffering from Crohn’s disease attested after biopsy
48	Wilson’s disease	41 Persons suffering from Wilson’s disease
49	Multiple neurofibromatosis (Recklinghausen)	42 Persons suffering from multiple neurofibromatosis syndrome (Recklinghausen) recurring systematically
50	Multiple myeloma	43 Persons suffering from multiple myeloma
51	Sarcoidosis	44 Persons suffering from sarcoidosis receiving major immunosuppressive therapy or having received major immunosuppressive therapy in the past and following a different pharmaceutical treatment related to this disease in the present due to lung or/and central nervous system infection
52	Autoimmune hepatitis	45 Persons suffering from autoimmune hepatitis receiving major immunosuppressive therapy or having received major immunosuppressive therapy in the past and following a different pharmaceutical treatment related to this disease in the present.
53	Glomerulonephritis	79 Persons suffering from glomerulonephritis receiving major immunosuppressive therapy (azathioprine, mycophenolic acid, cyclophosphamide, calcineurin inhibitors, rituximab) or high dosage of corticosteroids (Prednisone more than 0,5 mg/kg of body weight)
54	Total laryngectomy	46 Persons submitted to total laryngectomy
55	Brain craniopharyngioma	47 Persons suffering from brain craniopharyngioma
56	Systemic lupus erythematosus	48 Persons suffering from systemic lupus erythematosus receiving major immunosuppressive therapy or having received major immunosuppressive therapy in the past and following a different pharmaceutical treatment in the present related to this disease due to kidneys or/and central nervous system or/and serous membranes or/and blood infection
57	Systemic scleroderma	49 Persons suffering from systemic scleroderma with diffuse skin infection
58	Short bowel syndrome	75 Persons suffering from short bowel syndrome
59	Ulcerative colitis under pharmaceutical treatment	50 Persons suffering from ulcerative colitis receiving major immunosuppressive therapy or having received major immunosuppressive therapy in the past and following a different pharmaceutical treatment related to this disease in the present
60	Ulcerative colitis submitted to (procto)colectomy	51 Persons suffering from ulcerative colitis submitted to total proctocolectomy and permanent ileostomy or subtotal colectomy with ileocolic anastomosis or created ileoanal pouch
61	Autoimmune thrombocytopenia	52 Persons suffering from autoimmune hemolytic anemia or autoimmune thrombocytopenia receiving major immunosuppressive therapy
62	Juvenile idiopathic arthritis	54 Persons suffering from continuously active juvenile idiopathic arthritis after the age of 14 years despite the biological treatment
63	Acquired immunodeficiency syndrome (AIDS)	55 Persons suffering from acquired immunodeficiency syndrome (AIDS) under antiretroviral therapy
64	Paroxysmal nocturnal hemoglobinuria	56 Persons suffering from paroxysmal nocturnal hemoglobinuria in need of chronic regular transfusions
65	Idiopathic thrombocytopenic purpura	-
66	Autoimmune hemolytic anemia	52 Persons suffering from autoimmune hemolytic anemia or autoimmune thrombocytopenia receiving major immunosuppressive therapy
67	Klippel-Feil syndrome	53 Persons suffering from the Klippel-Feil syndrome
68	Rare syndromes – diseases	57 Persons suffering from various rare congenital, hereditary or acquired syndromes – diseases characterized by severe clinical manifestations deemed disabled with a degree of disability of at least 67%; to be examined on case-by-case basis
69	Klipper Trenaunay-Weber Syndrome	58 Persons suffering from Klipper Trenaunay-Weber syndrome
70	Mucopolysaccharidoses Type 6	59 Persons suffering from mucopolysaccharidoses Type 6
71	Dermatomyositis	60 Persons suffering from dermatomyositis receiving major immunosuppressive therapy or having received major immunosuppressive therapy in the past and following a different pharmaceutical treatment in the present related to this disease
72	Muckle Wells syndrome	61 Persons suffering from Muckle Wells syndrome (symptomatic disease with conventional clinical picture with a confirmed diagnosis by a pediatrician with experience in rheumatic diseases, genetic confirmatory testing for NALP3 cryopyrin mutation desired but not mandatory, since mutations are not attested in every patient, treatment with biological agents such as Interleukin IL-1 inhibitors)
73	Hereditary angioedema	62 Persons suffering from laboratory confirmed severe hereditary angioedema
74	Benign pontine tumor	63 Persons suffering from benign pontine tumor with a degree of disability of at least 67%
75	Aneurysm rupture with bleeding and hydrocephalus	64 Persons suffering from aneurysm rupture with bleeding and hydrocephalus with a degree of disability of at least 67%
76	Congenital hemolytic anemia or Diamond Blackfan anemia	05 Persons suffering from congenital hemolytic anemias undergoing blood transfusions or having severe clinical manifestations deemed disabled with a degree of disability of at least 67% (Mediterranean anemia/ Beta thalassemia/Thalassemia major, sickle cell anemia, micro-sickle cell anemia, persons suffering from Mediterranean anemia/ Beta thalassemia/Thalassemia major undergoing multiple blood transfusions, hemolytic anemia due to pyruvate kinase deficiency, Diamond Blackfan anemia)
77	Dyserythropoietic anemia	65 Persons suffering from dyserythropoietic anemia confirmed with bone marrow biopsy and long-term need for transfusions
78	Tuberous sclerosis or Bourneville disease	66 Persons suffering from tuberous sclerosis or Bourneville disease (phakomatosis of the central nervous system with various complications of the central nervous system, such as abnormal gait, difficulty with fine motor skills, concentration problems, fatigue etc)
79	Marfan syndrome	67 Persons suffering from Marfan syndrome
80	Crouzon syndrome or craniofacial dysostosis	68 Persons suffering from Crouzon syndrome or craniofacial dysostosis
81	Melorheostosis	69 Persons suffering from melorheostosis with 80% degree of disability
82	Ichthyosiform erythroderma	70 Persons suffering from ichthyosiform erythroderma with 67% degree of disability
83	Pharmacoresistant epilepsy	71 Persons suffering from pharmacoresistant epilepsy with 67% degree of disability
84	Systemic mastocytosis	72 Persons suffering from systemic mastocytosis confirmed with bone marrow biopsy and the level of tryptase in the blood
85	Kawasaki disease	73 Persons suffering from Kawasaki disease along with coronary artery disease or giant coronary artery aneurysms
86	Lamellar ichthyosis	74 Persons suffering from lamellar ichthyosis
87	Idiopathic nephrotic syndrome	76 Persons suffering from idiopathic nephrotic syndrome receiving major immunosuppressive therapy at least one (1) year after the diagnosis (prednisone dosage of at least >0,5 mg/kg in combination with cyclophosphamide, calcineurin inhibitors, mycophenolic acid or biological agents such as rituximab)
88	Vasculitis/Angiitis	77 Persons suffering from vasculitis/angiitis receiving biological therapy or major immunosuppressive therapy or having received major immunosuppressive therapy in the past following a different treatment in the present related to this disease
89	Severe congenital immunodeficiencies	78 Persons suffering from severe congenital immunodeficiencies under immunoglobulin replacement therapy
90	Acquired Immunodeficiency Syndrome (Stage C)	80 Persons suffering from acquired immunodeficiency syndrome (HIV Infection Stage C) under antiretroviral therapy on gravity level 3, that is with opportunistic infections: Pneumonia caused by Pneumocystis jiroveci, cerebral toxoplasmosis, fungal esophagitis, cryptosporidiosis, microsporidiosis, tuberculosis, infiltrative form of cervical cancer, Kaposi's sarcoma, lymphomas, neurocognitive disorders, pervasive mycobacterial disease, avium complex, cryptococcal meningitis, progressive multifocal leukoencephalopathy, wasting syndrome
91	Takayasu’s Arteritis	81 Persons suffering from Takayasu’s Arteritis receiving biological treatment or major immunosuppressive therapy
92	Aplastic anemia	82 Persons suffering from aplastic anemia
93	Ornithine Transcarbamylase Deficiency (OTD)	83 Persons suffering from Ornithine Transcarbamylase Deficiency (OTD)
94	Spinal Muscular Atrophy (SMA)	84 Persons suffering from Spinal Muscular Atrophy (SMA) deemed disabled with a degree of disability of at least 67%
95	Systemic Langerhans Cell Histiocytosis	85 Persons suffering from Systemic Langerhans Cell Histiocytosis
96	Guillain-Barré Neurological Syndrome	86 Persons suffering from Guillain-Barré neurological syndrome deemed disabled with a degree of disability of at least 67%
97	Ischemic Cerebral Stroke	87 Persons suffering from Ischemic Cerebral Stroke deemed disabled with a degree of disability of at least 67%
98	Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)	88 Persons suffering from Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
99	Lacrimo-auriculo-dento-digital (LADD) Syndrome	89 Persons suffering from Lacrimo-auriculo-dento-digital (LADD) Syndrome
100	Progressive Familial Intrahepatic Cholestasis type 3 (PFIC3)	90 Persons suffering from Progressive Familial Intrahepatic Cholestasis type 3 (PFIC3)
101	Pervasive Developmental Disorder	91 Persons suffering from Pervasive Developmental Disorder deemed disabled with a degree of disability of at least 67%
102	Spondyloarthritis Ankylopoetica (Axial/Ankylosing Spondyloarthritis) or Psoriatic Spondyloarthritis	92 Persons suffering from Spondyloarthritis Ankylopoetica (Axial/Ankylosing Spondyloarthritis) or Psoriatic Spondyloarthritis receiving biological treatment or targeted therapy deemed disabled with a degree of disability of at least 67%
103	Congenital Adrenal Hyperplasia	93 Persons suffering from Congenital Adrenal Hyperplasia
104	Idiopathic myoclonic epilepsy	94 Persons suffering from Idiopathic myoclonic epilepsy deemed disabled with a degree of disability of at least 67%
105	Right Spastic Hemiplegia Cerebral Palsy	95 Persons suffering from Right Spastic Hemiplegia Cerebral Palsy deemed disabled with a degree of disability of at least 67%
106	Cerebral Palsy	96 Persons suffering from Cerebral Palsy deemed disabled with a degree of disability of at least 67%
107	Spontaneous Intercranial Hypotension, Chiari I Malformation	97 Persons suffering from Spontaneous Intercranial Hypotension, Chiari I Malformation deemed disabled with a degree of disability of at least 67%
108	Ollier Disease	98 Persons suffering from Ollier Disease deemed disabled with a degree of disability of at least 67%
109	Hypophosphatemic rickets	99 Persons suffering from Hypophosphatemic rickets
110	Chronic sensorimotor axonal polyneuropathy	100 Persons suffering from Chronic sensorimotor axonal polyneuropathy deemed disabled with a degree of disability of at least 67%
111	Primary cardiac tumors	101 Primary cardiac tumors
112	Serious complex congenital heart diseases a) with pulmonary vascular disease and pulmonary hypertension including Eisenmenger Syndrome b) with cyanotic congenital heart diseases c) double outlet right ventricle d) Fontan or Fontan-type circulation e) Interrupted aortic arch f) pulmonary atresia g) systemic right ventricle h) single ventricle i) truncus arteriosus j) complex discordant atrioventricular or ventriculoarterial connections	102 Persons suffering from serious complex congenital heart diseases a) with pulmonary vascular disease and pulmonary hypertension including Eisenmenger Syndrome b) with cyanotic congenital heart diseases c) double outlet right ventricle d) Fontan or Fontan-type circulation e) Interrupted aortic arch f) pulmonary atresia g) systemic right ventricle h) single ventricle i) truncus arteriosus j) complex discordant atrioventricular or ventriculoarterial connections
113	Persons suffering from moderate complex or other congenital heart diseases as long as they: a) use defibrillator, b) receive treatment for heart failure, c) had high bioindicators (BNP, NTpro BNP) before treatment	103 Persons suffering from moderate complex or other congenital heart diseases as long as they: a) use defibrillator, b) receive treatment for heart failure, c) had high bioindicators (BNP, NTpro BNP) before treatment
114	Cardiomyopathy with low ejection fraction (40% or less)	104 Persons suffering from Cardiomyopathy with low ejection fraction (40% or less)
115	Ebstein anomaly with heart failure	105 Persons suffering from Ebstein anomaly with heart failure
990	Disability degree certified by a Disability Certification Centre (KEPA)	-
991	Learning disabilities [NKUA code]	-
992	ADHD (Attention-deficit/hyperactivity disorder) [NKUA code]	-
993	Pervasive neurodevelopmental disorders [NKUA code]	-
994	Psychological disorders [NKUA code]	-

Showing 1 to 120 of 120 entries